Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer.
- Resource Type
- Article
- Authors
- Bauman, Julie E.; Saba, Nabil F.; Roe, Denise; Bauman, Jessica R.; Kaczmar, John; Bhatia, Aarti; Muzaffar, Jameel; Julian, Ricklie; Wang, Steven; Bearelly, Shethal; Baker, Audrey; Steuer, Conor; Giri, Anshu; Burtness, Barbara; Centuori, Sara; Caulin, Carlos; Klein, Robert; Saboda, Kathylynn; Obara, Stefanie; Chung, Christine H.
- Source
- Journal of Clinical Oncology; 8/1/2023, Vol. 41 Issue 22, p3851-3862, 12p
- Subject
- Language
- ISSN
- 0732183X